Updated: Eli Lilly blames Biden's IRA for cancer drug discontinuation as the new pharma playbook takes shape
Eli Lilly laid blame Tuesday afternoon on President Joe Biden’s Inflation Reduction Act as the reason it scrapped a $40 million cancer drug.
As part …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
